{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:26:27Z","timestamp":1780446387329,"version":"3.54.1"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2967\/jnumed.123.265691","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T15:13:56Z","timestamp":1689866036000},"page":"1385-1391","source":"Crossref","is-referenced-by-count":9,"title":["Performance of<sup>68<\/sup>Ga-Labeled Fibroblast Activation Protein Inhibitor PET\/CT in Evaluation of Erdheim\u2013Chester Disease: A Comparison with<sup>18<\/sup>F-FDG PET\/CT"],"prefix":"10.2967","volume":"64","author":[{"given":"Jiangyu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023091409501486000_64.9.1385.1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0913"},{"key":"2023091409501486000_64.9.1385.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0653-6"},{"key":"2023091409501486000_64.9.1385.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570937"},{"key":"2023091409501486000_64.9.1385.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0944-4"},{"key":"2023091409501486000_64.9.1385.5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim\u2013Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood."},{"key":"2023091409501486000_64.9.1385.6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00259-020-05047-8","article-title":"18F-FDG PET\/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim\u2013Chester disease: results from 50 patients in a registry study","volume":"48","author":"Kirchner","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501486000_64.9.1385.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.200741"},{"key":"2023091409501486000_64.9.1385.8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/neuonc\/noaa008","article-title":"Neurologic and oncologic features of Erdheim\u2013Chester disease: a 30-patient series","volume":"22","author":"Bhatia","year":"2020","journal-title":"Neuro Oncol."},{"key":"2023091409501486000_64.9.1385.9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","article-title":"Vemurafenib for BRAF V600-mutant Erdheim\u2013Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"JAMA Oncol."},{"key":"2023091409501486000_64.9.1385.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210443"},{"key":"2023091409501486000_64.9.1385.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"2023091409501486000_64.9.1385.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210435"},{"key":"2023091409501486000_64.9.1385.13","doi-asserted-by":"crossref","first-page":"e1440929","DOI":"10.1080\/2162402X.2018.1440929","article-title":"The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim\u2013Chester disease","volume":"7","author":"Pacini","year":"2018","journal-title":"OncoImmunology."},{"key":"2023091409501486000_64.9.1385.14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/RLU.0000000000003491","article-title":"68Ga-DOTA-FAPI-04 PET\/CT in Erdheim\u2013Chester disease","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2023091409501486000_64.9.1385.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-561381"},{"key":"2023091409501486000_64.9.1385.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-313510"},{"key":"2023091409501486000_64.9.1385.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-294108"},{"key":"2023091409501486000_64.9.1385.18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.kint.2022.09.027","article-title":"Clinical phenotypes and long-term outcome of kidney involvement in Erdheim\u2013Chester histiocytosis","volume":"103","author":"Chazal","year":"2023","journal-title":"Kidney Int."},{"key":"2023091409501486000_64.9.1385.19","doi-asserted-by":"crossref","unstructured":"Azoulay LD Bravetti M Cohen-Aubart F . Prevalence, patterns and outcomes of cardiac involvement in Erdheim\u2013Chester disease. Eur Heart J. 2022;ehac741.","DOI":"10.1093\/eurheartj\/ehac741"},{"key":"2023091409501486000_64.9.1385.20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3324\/haematol.2021.280510","article-title":"Erdheim\u2013Chester disease: look it in the eye. An orbital magnetic resonance imaging study","volume":"107","author":"Haroche","year":"2022","journal-title":"Haematologica."},{"key":"2023091409501486000_64.9.1385.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1676-y"},{"key":"2023091409501486000_64.9.1385.22","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318156bc9b"},{"key":"2023091409501486000_64.9.1385.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.rlu.0000249758.49841.fa"},{"key":"2023091409501486000_64.9.1385.24","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.ejrad.2015.04.022","article-title":"The role of 18FDG, 18FDOPA PET\/CT and 99mTc bone scintigraphy imaging in Erdheim\u2013Chester disease","volume":"84","author":"Garc\u00eda-G\u00f3mez","year":"2015","journal-title":"Eur J Radiol."},{"key":"2023091409501486000_64.9.1385.25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/RLU.0b013e31828da5e6","article-title":"FDG PET images in a patient with Erdheim\u2013Chester disease","volume":"39","author":"Sioka","year":"2014","journal-title":"Clin Nucl Med."},{"key":"2023091409501486000_64.9.1385.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.244723"},{"key":"2023091409501486000_64.9.1385.27","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","article-title":"IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET\/CT","volume":"46","author":"Luo","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501486000_64.9.1385.28","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1097\/RLU.0000000000003015","article-title":"68Ga-FAPI PET\/CT in assessment of liver nodules in a cirrhotic patient","volume":"45","author":"Zhao","year":"2020","journal-title":"Clin Nucl Med."},{"key":"2023091409501486000_64.9.1385.29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00259-020-05028-x","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/CT imaging in a case of prostate cancer with shoulder arthritis","volume":"48","author":"Xu","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501486000_64.9.1385.30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/RLU.0000000000003279","article-title":"68Ga-FAPI and 18F-FDG PET\/CT images in a patient with extrapulmonary tuberculosis mimicking malignant tumor","volume":"45","author":"Gu","year":"2020","journal-title":"Clin Nucl Med."},{"key":"2023091409501486000_64.9.1385.31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00259-020-04941-5","article-title":"[18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of tuberculous lesions","volume":"48","author":"Hao","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501486000_64.9.1385.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.215913"},{"key":"2023091409501486000_64.9.1385.33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/pin.12663","article-title":"An autopsy case report: differences in radiological images correlate with histology in Erdheim\u2013Chester disease","volume":"68","author":"Ohara","year":"2018","journal-title":"Pathol Int."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.265691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:52:11Z","timestamp":1694710331000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.265691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2967\/jnumed.123.265691"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.265691","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}